MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202441097191 A) filed by Kalaiyarasi Mani; Gobhika S; Deepika K; Muthu Santhiya M; and Kodeeswari P on December 09, 2024, for Iv Drug Administration System With Infiltration Detection.
Inventors include Kalaiyarasi Mani; Gobhika S; Deepika K; Muthu Santhiya M; and Kodeeswari P.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: Intravenous (IV) therapy is a vital medical procedure that is frequently used to deliver fluids, medications, and nutrients directly into a patient's bloodstream. However, despite its widespread use, complications like infiltration and extravasation present serious risks to patient safety. Infiltration, which is defined as the leakage of IV fluids into surrounding tissues, affects between 23% and 78% of patients receiving IV therapy and can cause localized pain, swelling, and in severe cases, tissue necrosis, while extravasation, which is the escape of vesicant drugs into surrounding tissues, could result in severe tissue damage, necrosis, and long-term functional impairment. These statistics highlight the need for innovative solutions to reduce risks and improve IV therapy safety. The development of air bubbles in the IV line is another serious problem with IV therapy. Air embolisms brought on by these bubbles are uncommon, but if they go unnoticed, they can have serious and even deadly consequences. Conventional IV systems rely on manual monitoring, which is time-consuming and prone to mistakes. The need for technology solutions to increase the safety and dependability of IV therapy is growing as automation and data-driven healthcare have become more and more important. An automated IV drug administration system that combines cutting-edge sensor technology and Internet of Things-based solutions is presented in this research to address these issues. With capabilities like bubble detection—which is accomplished in real-time by utilizing an LDR sensor and laser to detect air bubbles—the system is made to guarantee patient safety. To detect the accumulation of extracellular fluid in the tissues surrounding the catheter, an AD8232 module equipped with an ECG sensor is also used to detect infiltration. To ensure accurate control of the IV fluid flow rate, the system additionally includes flow control via a solenoid valve. All sensor data is processed by an ESP32 microcontroller before being sent over the MQTT protocol. A web-based dashboard shows the data directly, giving medical professionals access to data analytics and real-time visualization. The dashboard, which was created with JavaScript, HTML, and CSS, guarantees quick and easy access to patient's vital data, facilitating informed decisions and effective IV therapy monitoring. By combining these qualities, the system improves patient safety, lessens the effort for medical personnel, and decreases dangers related to IV therapy. By filling important holes in conventional methods, this novel method of IV drug administration provides a safer, more effective, and more cutting-edge option. It draws attention to how sensor-based monitoring and Internet of Things technologies have the potential to revolutionize healthcare delivery and guarantee better patient outcomes.
Disclaimer: Curated by HT Syndication.
